Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
How blocking one protein regenerates knee cartilage in aging mice and human t...
BY THE OPTIMIST DAILY EDITORIAL TEAM A Stanford Medicine study has identified a protein that roughly doubles in aging joints and blocks cartilage from ...
Read MoreHow heat domes form, intensify, and what they do to the body
BY THE OPTIMIST DAILY EDITORIAL TEAM More than 1,300 people die from extreme heat in the United States each year. The events behind the ...
Read MoreFeeling the gym blues? 7 strategies to kick your body comparison habit
You've prepared for that sizzling aerobic dancing class and are looking forward to crushing your workout. Unfortunately, the gym becomes an unanticipated battleground for ...
Read More3D-printed polypill covers all your medication for the entire day
Keeping track of many medicines and dosages might make it difficult to remember to take medication. However, a new invention in healthcare could provide ...
Read More
